The drug inquiry response process in the pharmaceutical firm is examined by the types of drug inquiries for which responses are provided. Inquiries are categorized according to their general nature, the time value of the information requested, the difficulty in conducting the literature analysis or in securing required internal data, and the complexity of the evaluation and internal review procedures used in preparing responses. Strategies are suggested for reducing the time required for generating satisfactory responses according to each of these inquiry types.
HopkinsFGalligherCLevineA.Medical affairs and drug information practices within the pharmaceutical industry: results of a benchmarking survey. Drug Inf J.1999; 33:69–85.
2.
BakerRPUser survey of an industry-based drug information service. Drug Inf J.1990;24:235–243.
3.
GasperinoJLDrug information services at Pfizer Labs. Am J Hosp Pharm.1990;47:1998–1999.
4.
WatanabeASConnerCSPrinciples of Drug Information Services 1978.Hamilton, IL: Drug Intelligence Publications; 1978.
5.
GaspicMBiondiLFlowersT.Medical information on demand. Drug Inf J.1998;32:289–292.
6.
RawnP.Drug Information & Safety Department survey of customer needs and satisfaction. Drug Inf J.1999;33:525–539.
